Dr. Reddy’s Q1 net plunges 69% to ₹435.6 cr on lower revenue
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
· 7/22/2026, 2:16:14 PM· 2 min read
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
Read original story →Related stories
business
Former Lloyd's of London boss's relationship breached rules, firm says
business
Indian economy navigated well external uncertainties: RBI Bulletin
business
IndusInd bank’s Q1FY27 PAT up 47% on lower provisions
business